Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open study of BF 2.649 with a mood stabilizer in depressed bipolar patients
2005-005011-25Phase 2Completed
- Sponsor
- Bioprojet
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pitolisant in bipolar disorder (BD), sponsored by Bioprojet. Primary endpoint: Antidepressant response by MADRS. Started Nov 2005; status: completed.
02
Drugs
pitolisant
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on 2005-005011-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005011-25.